|
Symbol
|
Z0BBBZ | Z0BE4Z | Z0BHFZ | NEMDTZ | Z0BLAZ | Z0BLFZ | Z0BM8Z | Z0BMVZ | Z0BNEZ | Z0BS6Z | Z0BS8Z | Z0BSIZ | LINDIZ | Z0BUHZ | Z0BUYZ | Z0BV1Z | Z0BW4Z | Z0BW5Z | Z0BWWZ | BMYDIZ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate | Discount Certificate |
|
Sous-jacent
|
Ypsomed Hldg. AG | Roche PS | Novartis AG | Newmont Corp. | Sika AG | Novartis AG | PolyPeptide Aktie | Alcon | Bachem Hldg. AG | Nestlé S.A. | Roche PS | BASF SE | Linde Aktie Plc. | Nestlé S.A. | Givaudan | VAT Group | Roche PS | Holcim AG | Lonza Group N | Bristol-Myers Squibb Co. |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
06.07.2026 | 28.07.2026 | 20.08.2026 | 20.08.2026 | 08.09.2026 | 10.09.2026 | 16.09.2026 | 23.09.2026 | 28.09.2026 | 21.10.2026 | 22.10.2026 | 28.10.2026 | 05.11.2026 | 11.11.2026 | 17.11.2026 | 18.11.2026 | 20.11.2026 | 23.11.2026 | 27.11.2026 | 29.01.2027 |
|
Cap
|
425,00 | 270,00 | 100,00 | 62,50 | 180,00 | 105,00 | 26,00 | 60,00 | 60,00 | 80,00 | 275,00 | 42,50 | 415,00 | 77,50 | 3 000,00 | 250,00 | 305,00 | 65,00 | 535,00 | 57,50 |
| Discount | -0,48% | -0,22% | -0,25% | 0,21% | 2,94% | 0,01% | -0,03% | 1,59% | 1,64% | 1,80% | 0,32% | 2,44% | 1,46% | 1,39% | 1,30% | -0,30% | 1,80% | 1,94% | 3,67% | 11,29% |
| rendement max. p.a. | n/a | -3,16% | -1,87% | 1,58% | 35,17% | 0,05% | -0,13% | 47,23% | 7,00% | 6,09% | 1,05% | 7,82% | 4,32% | 3,92% | 3,52% | -0,79% | 4,77% | 5,05% | 9,46% | 22,13% |
| Demande | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Offre | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |